4//SEC Filing
Dahms Bradford D. 4
Accession 0000950170-25-095668
CIK 0001798749other
Filed
Jul 13, 8:00 PM ET
Accepted
Jul 14, 7:12 PM ET
Size
5.6 KB
Accession
0000950170-25-095668
Insider Transaction Report
Form 4
Dahms Bradford D.
Chief Financial Officer
Transactions
- Award
Stock Option (Right to Buy)
2025-07-14+526,000→ 526,000 totalExercise: $9.00Exp: 2035-07-14→ Common Stock (526,000 underlying)
Footnotes (1)
- [F1]This option represents a right to purchase 526,000 shares of the Issuer's common stock, one quarter of which will vest on July 14, 2026, with the remaining three quarters vesting in equal monthly installments over the following three years, subject to the Reporting Person's continued service to the Issuer on each such vesting date.
Documents
Issuer
Jade Biosciences, Inc.
CIK 0001798749
Entity typeother
Related Parties
1- filerCIK 0001787307
Filing Metadata
- Form type
- 4
- Filed
- Jul 13, 8:00 PM ET
- Accepted
- Jul 14, 7:12 PM ET
- Size
- 5.6 KB